IDSA GUIDELINES Bundle (free trial)

Fever and Neutropenia

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/53994

Contents of this Issue

Navigation

Page 13 of 15

Treatment Figure 2. Reassess After 2-4 Days of Empirical Antibiotic Therapy Day 2-4 After Empirical Antibiotic Therapy Low Risk Unexplained fever > Persistent fever > Clinically unstable Hospitalize (if outpatient) for broad-spectrum IV antibiotics Continue oral or IV antibiotics until ANC > 0.5 x 109 and rising Modify antibiotics according to culture results and/ or infection site Continue antibiotics for 7-14 day course as appropriate for documented infection, or longer– ie, until ANC > 0.5 x 109 and rising /L /L RESPONDING > Defervesced > Cultures negative High Risk Unexplained fever > Persistent fever > Stable clinically Documented infection Modify antibiotics according to culture results and/ or infection site > Defervesced > Cultures negative Continue antibiotics until ANC > 0.5 x 109 and rising No changes in empircal anibiotics Assess for infection sites NON-RESPONDING Recurrent fever during persistent neutropenia > Examine and re-image (CT, MRI) for new or worsening sites of infection > Culture/biopsy/drain sites of worsening infection: assess for bacterial, viral and fungal pathogens > Review antibiotic coverage for adequacy of dosing and spectrum > Consider adding empirical antifungal therapy > Broaden antimicrobial coverage for hemodynamic instability 12 /L

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Fever and Neutropenia